Insight into different phenotypic presentations of heart failure with preserved ejection fraction

Prog Cardiovasc Dis. 2023 Jul-Aug:79:80-88. doi: 10.1016/j.pcad.2023.07.003. Epub 2023 Jul 11.

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for half of all HF diagnoses, and its prevalence is increasing at an alarming rate. Lately, it has been recognized as a clinical syndrome due to diverse underlying etiology and pathophysiological mechanisms. The classic echocardiographic features of HFpEF have been well described as preserved ejection fraction (≥50%), left ventricular hypertrophy, and left atrial enlargement. However, echocardiography can play a key role in identifying the principal underlying mechanism responsible for HFpEF in the individual patient. The recognition of different phenotypic presentations of HFpEF (infiltrative, metabolic, genetic, and inflammatory) can assist the clinician in tailoring the appropriate management, and offer prognostic information. The goal of this review is to highlight several key phenotypes of HFpEF and illustrate the classic clinical scenario and echocardiographic features of each phenotype with real patient cases.

Keywords: Cardiac amyloidosis; Chronic kidney disease; Echocardiography; Heart failure with preserved ejection fraction; Hypertension; Obesity.

Publication types

  • Review

MeSH terms

  • Echocardiography
  • Heart Failure* / diagnosis
  • Heart Failure* / therapy
  • Humans
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Phenotype
  • Stroke Volume / physiology
  • Ventricular Function, Left / physiology